Icon
+91 94997 68112
Login Register

Doryx - (75, 80, 100, 150 mg Delayed release tablets)

Doxycycline Hyclate Mayne Pharma
75, 80, 100, 150 mg Delayed release tablets
Less Than $1000 mn
Less Than 5
More Than 5
None None
Less Than 5
Less Than 5
Used to treat many different bacterial infections, such as acne, urinary tract infections, intestinal infections, eye infections, gonorrhea, chlamydia, periodontitis (gum disease), and others. Doryx is also used to treat blemishes, bumps, and acne-like lesions caused by rosacea
Yes
*****, ***** & ****** **** *** ***** ** **** **** ** **** ****** *******- *** **, **** *** **** ************ *********. ******* *******, ****** & ******** ****** **** ***** **** ** **** *** **** ****** ** *** ****. ***** *** *****'* **** *** ****** ***-********* **** **** ******** **** ********* ********. ********** **** *******, ******, ******** ****** *** ****** ****** *** *******. ***** ** *** ********* ******** ****** ******** *** ******* ****** * ***** ***** **********. ******* ***** ******** ****** ******** (*****'* ******* ) **** ******** *** ******* ** *****. ****** *** ****** ****** **** *** ******** *** ******* ** ***. ***** * *** ******** ***. ** ** *** ******** ** ***** *** * **** ** *** ***** ** *** *** ******** ** **** *** ** ****** ** *** ********** *********.
Doryx Patent 1 Patent 2 Patent 3 Patent 4 Patent 5
***** *** *** ********* *** ********* *** ********* *** *********
***** *** *** ********* *** ********* *** ********* *** *********
****** ****** ******* *** ********* *** ********* *** ********* *** *********
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** *** \ ** **** **, **** *** ******** ************ *********
***** *** \ *** **** **, **** *** ******** ************ ******** ** *** **, ****
****** ****** *** \ ** **** **, **** ******* **** ****** **** ********
  1. *** **, **** : *****, ***** , ****** ****** ******** ****** ******** ***** ***** **** ** **** ****** '*** (*** **, ****).
  2. *** **, **** : ****** ******** ***** * **** ******* *** *** ***** ** ******** ***** ** **.
  3. *** **, **** : ****** ******** ***** * **** ******* ****** ** ****** ***** * **** ** **** ****** '***.
  4. *** **, **** : ****** ******** ***** * **** ******* ******* ** ******* ***** * **** ** **** ****** '***.
  5. *** **, **** : ****** ******** ***** * **** ******* ******** ****** ** ******** ****** ***** * **** ** **** ****** '***.
  6. *** *, **** : ********** *** ******* **** ******** ****** ***** *** ***** ** ********* *** *** *****.
  7. ****** *** **** : *** ******** ***** ******** *** ******* **** ** ***** *** ** **** ** ******* * ***** ** *** ****** ***** ******* **** *** ** * ******* ****** ***** ********* *** ****** ****.
  8. *** **** : ******* *** ** ****** **** ****** **** *** ****, ***** *********** **** *** ***** ******* *** ****. **** ****** ******** ***** * *********** ********** ****** ******* *****.
  9. *** **. **** : ******** ***** ******* ****** ********'* ** ******. ***** ******** **** ******** ** ******* *******.
  10. *** **, **** : ******* ******* ********** ******** *****'* ******.
  11. *** *, **** : ********** **** ****** *** ****** ****** *** ********* ***** *** ***** ** ********* *** *** ****. ******* ** **** **** ******** *** ******* ** ***.
  12. ***** **, **** : ***** ***** **** *****'* & *****'* **** ******* **** *** ******** ******'* ******* ******** ***** & ***** ****** ** ***** *** ********** ** ******. ** *** **** *** ***** ******** *** *** ***** ********* ** *** ******* ***** ***** ******** **** & ***** ****.
  13. *** **, **** : * *** ******** ** ***** *.*. ** ** *** ******** ** *****
  14. *** *, **** : ******** ****** ******** **, ***, *** ** *****.
  15. *** *, **** : ******* ******** **** ** *****. ***** *** ****** ******** **** ******** *** *** ******* *** ******* ***** ******** ****** ********.
  16. *** *, **** : ***** ***** ** **** *** **** ***** *** ***** ******** **** *** **** *********** *** *** **** ************.
  17. *** **, **** : * ********* *** ********** *** ******** *** ** *****, **** ********** **** ******* *******, *******, ******* *** ******* **** ******* & *****.
  18. *** **, **** : *****, ****** & ******** ******** **** *** *** ******* **** *** **** ******** *********** ******* *******, ** **, ** **, ** ** *** *** **, *** ******** *** ************* ** ** *********** *** **** *********** (****)
  19. *** *, **** : ******* ******** ***** ******** *** *** *** *********.

Doryx - (50 mg; Tablet delayed release)

Doxycycline Hyclate Mayne Pharma
50 mg; Tablet delayed release
Less Than $1000 mn
None
Less Than 5
Less Than 5
 None
Less Than 5
Less Than 5
None
No

Doryx - (200 mg; Tablet, delayed release)

Doxycycline Hyclate Mayne Pharma
200 mg; Tablet, delayed release
Less Than $1000 mn
None
Less Than 5
More Than 5
 None
Less Than 5
Less Than 5
None
No

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.   Privacy Policy.   Terms and Conditions.